Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Pattern Analysis of Galectin 1, 3, and 9 Serum Levels in Breast Cancer

Version 1 : Received: 23 June 2023 / Approved: 26 June 2023 / Online: 26 June 2023 (11:23:21 CEST)

A peer-reviewed article of this Preprint also exists.

Funkhouser, A.; Shuster, H.; Martin, J.C.; Edenfield, W.J.; Blenda, A.V. Pattern Analysis of Serum Galectins-1, -3, and -9 in Breast Cancer. Cancers 2023, 15, 3809. Funkhouser, A.; Shuster, H.; Martin, J.C.; Edenfield, W.J.; Blenda, A.V. Pattern Analysis of Serum Galectins-1, -3, and -9 in Breast Cancer. Cancers 2023, 15, 3809.

Abstract

Galectins have been shown to have roles in cancer progression via contributions to angiogenesis, metastasis, cell division, and evasion of immune destruction. This study analyses galectin-1, -3, and -9 serum concentrations in breast cancer patients by enzyme-linked immunosorbent assay (ELISA) against the characteristics of the patient and tumor such as stage, molecular subtype, and receptor expression. Galectin-9 was found to be statistically significantly increased in HER2 enriched tumors as well as being reduced in patients with hormone receptor positive tumors and increased in patients with HER2 amplified tissues. Galectin-1 was found to be statistically significantly increased in the serum of patients who had undergone hormonal, immunotherapy, or chemotherapy. These findings provide insight as to the changes in galectin levels during cancer progress, response to treatment and molecular phenotype. These findings are valuable in the further understanding of the relationships of galectin and tumor biology and can inform future research on therapeutic targets for galectin inhibitors and the utility of galectin biomarkers.

Keywords

galectin; breast neoplasm; molecular subtype; oncotype; galectin-1; galectin-3; galectin-9

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.